Literature DB >> 8028478

Glycation increases the permeability of proteins across the blood-nerve and blood-brain barriers.

J F Poduslo1, G L Curran.   

Abstract

Our previous investigations have demonstrated increased permeability across the blood-nerve barrier of human plasma albumin after glycation with D-glucose [J.F. Poduslo and G.L. Curran, Proc. Natl. Acad. Sci. USA, 89 (1992) 2218-2222]. In the present investigation, the generality of this observation was evaluated by measuring the permeability coefficient-surface area product (PS) after correction for the residual plasma volume (Vp) across the blood-nerve barrier (BNB), as well as the blood-brain barrier (BBB), for nerve growth factor (NGF) and human IgG after in vitro glycation with D-glucose using an i.v. bolus injection technique in the cannulated brachial vein and artery of normal adult rats. Glycated proteins (gNGF and gIgG) had significantly decreased circulating plasma half-lives compared to the non-glycated proteins. The PS across the BNB obtained for gNGF was significantly increased compared to NGF with a 2.0-fold increase observed after 8 weeks of glycation and a 5.1-fold increase at 21 weeks of glycation. The Vp measurement for NGF and gNGF across the BNB was not significantly different at 8 weeks of glycation but was 1.3-fold greater at 21 weeks of glycation. The PS across the BBB for gNGF was about 2-fold greater than NGF with a glycation time of 8 weeks and 3.2-3.6-fold greater with a glycation time of 21 weeks for six different brain regions. No changes were observed in the Vp for any of the brain regions for gNGF compared to NGF. The PS across the BNB for gIgG compared to IgG was significantly greater with a 4.1-fold relative increase and no significant difference in the Vp values.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8028478     DOI: 10.1016/0169-328x(94)90222-4

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  11 in total

Review 1.  Development of neuropeptide drugs that cross the blood-brain barrier.

Authors:  Richard D Egleton; Thomas P Davis
Journal:  NeuroRx       Date:  2005-01

Review 2.  CNS drug delivery: opioid peptides and the blood-brain barrier.

Authors:  Ken A Witt; Thomas P Davis
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

3.  Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.

Authors:  Joseph F Poduslo; Geoffry L Curran; Jane A Peterson; Daniel J McCormick; Abdul H Fauq; Murad A Khan; Thomas M Wengenack
Journal:  Biochemistry       Date:  2004-05-25       Impact factor: 3.162

4.  Effects of valproic Acid on axonal regeneration and recovery of motor function after peripheral nerve injury in the rat.

Authors:  Ting Rao; Fei Wu; Danmou Xing; Zhengren Peng; Dong Ren; Wei Feng; Yan Chen; Zhiming Zhao; Huan Wang; Junweng Wang; Wusheng Kan; Qingsong Zhang
Journal:  Arch Bone Jt Surg       Date:  2014-03-15

Review 5.  Delivery of therapeutic peptides and proteins to the CNS.

Authors:  Therese S Salameh; William A Banks
Journal:  Adv Pharmacol       Date:  2014-08-22

Review 6.  CNS active O-linked glycopeptides.

Authors:  Evan M Jones; Robin Polt
Journal:  Front Chem       Date:  2015-06-24       Impact factor: 5.221

7.  Can amphipathic helices influence the CNS antinociceptive activity of glycopeptides related to β-endorphin?

Authors:  Yingxue Li; Lindsay St Louis; Brian I Knapp; Dhanasekaran Muthu; Bobbi Anglin; Denise Giuvelis; Jean M Bidlack; Edward J Bilsky; Robin Polt
Journal:  J Med Chem       Date:  2014-03-07       Impact factor: 7.446

Review 8.  Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain.

Authors:  Pegah Varamini; Istvan Toth
Journal:  Front Pharmacol       Date:  2013-12-13       Impact factor: 5.810

9.  Zonisamide Enhances Neurite Elongation of Primary Motor Neurons and Facilitates Peripheral Nerve Regeneration In Vitro and in a Mouse Model.

Authors:  Hideki Yagi; Bisei Ohkawara; Hiroaki Nakashima; Kenyu Ito; Mikito Tsushima; Hisao Ishii; Kimitoshi Noto; Kyotaro Ohta; Akio Masuda; Shiro Imagama; Naoki Ishiguro; Kinji Ohno
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

10.  Glycoconjugated Metallohelices have Improved Nuclear Delivery and Suppress Tumour Growth In Vivo.

Authors:  Hualong Song; Simon J Allison; Viktor Brabec; Hannah E Bridgewater; Jana Kasparkova; Hana Kostrhunova; Vojtech Novohradsky; Roger M Phillips; Jitka Pracharova; Nicola J Rogers; Samantha L Shepherd; Peter Scott
Journal:  Angew Chem Int Ed Engl       Date:  2020-07-07       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.